A

Aier Eye Hospital Group Co Ltd
SZSE:300015

Watchlist Manager
Aier Eye Hospital Group Co Ltd
SZSE:300015
Watchlist
Price: 14.28 CNY -4.86% Market Closed
Market Cap: 132B CNY
Have any thoughts about
Aier Eye Hospital Group Co Ltd?
Write Note

Net Margin
Aier Eye Hospital Group Co Ltd

17.6%
Current
16%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.6%
=
Net Income
3.6B
/
Revenue
20.6B

Net Margin Across Competitors

Country CN
Market Cap 133.2B CNY
Net Margin
18%
Country US
Market Cap 83.9B USD
Net Margin
9%
Country SA
Market Cap 98B SAR
Net Margin
22%
Country ZA
Market Cap 24.9B Zac
Net Margin
17%
Country ZA
Market Cap 20.7B Zac
Net Margin
5%
Country MY
Market Cap 63.3B MYR
Net Margin
11%
Country US
Market Cap 13.7B USD
Net Margin
15%
Country US
Market Cap 13.1B USD
Net Margin
7%
Country TH
Market Cap 421.1B THB
Net Margin
15%
Country IN
Market Cap 997.2B INR
Net Margin
5%
Country IN
Market Cap 971.9B INR
Net Margin
19%
No Stocks Found

Aier Eye Hospital Group Co Ltd
Glance View

Market Cap
133.2B CNY
Industry
Health Care

Aier Eye Hospital Group Co., Ltd., founded in 2001 and headquartered in Changsha, China, has emerged as a leading player in the ophthalmology healthcare sector in Asia. Starting as a single eye clinic, it has grown exponentially to encompass a vast network of over 60 hospitals and numerous outpatient service centers across China and beyond. The company focuses on providing comprehensive eye care services, including cataract surgery, myopia treatment, and other advanced healthcare solutions, leveraging cutting-edge technology and innovative techniques. With a dedicated team of skilled specialists and a commitment to enhancing patient outcomes, Aier aims to address the increasing demand for vision care in a rapidly aging population, underpinned by a robust business model that merges quality healthcare delivery with strategic expansion. As an investor, Aier Eye Hospital presents a compelling opportunity in the burgeoning health sector. With healthcare spending expected to rise in China and globally, Aier's prominence in eye care positions it well to tap into this growing market. The company's commitment to research and development ensures continuous innovation and adaptation to emerging healthcare trends, setting it apart from traditional healthcare providers. Furthermore, Aier's expansion strategy, including potential international outreach, offers a promise of sustained growth. By investing in Aier, one is not just supporting a service provider but joining a forward-thinking healthcare institution that is poised to redefine eye care and generate significant returns.

Intrinsic Value
18.1 CNY
Undervaluation 21%
Intrinsic Value
Price
A

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
17.6%
=
Net Income
3.6B
/
Revenue
20.6B
What is the Net Margin of Aier Eye Hospital Group Co Ltd?

Based on Aier Eye Hospital Group Co Ltd's most recent financial statements, the company has Net Margin of 17.6%.